Psychedelics — a class of hallucinogenic drugs with powerful mind-altering capabilities — are having a moment.
The future of psychedelics policy is being shaped today by a wide range of interests, including healthcare workers, government regulators, pharmaceutical startups and traditional use advocates, whose efforts will determine where we go from here.
In this single-episode investigative podcast, released in May 2023, I explore how the relationship between U.S. law and psychedelic substances is changing.
Sam Reisman 